OA
Oak Associates Portfolio holdings
AUM
$1.53B
1-Year Return
20.93%
This Quarter Return
-7.31%
1 Year Return
+20.93%
3 Year Return
+113.44%
5 Year Return
+164.39%
10 Year Return
+515.4%
AUM
$1.64B
AUM Growth
-$239M
(-13%)
Cap. Flow
-$76.2M
Cap. Flow
% of AUM
-4.65%
Top 10 Holdings %
Top 10 Hldgs %
45.73%
Holding
139
New
1
Increased
10
Reduced
53
Closed
1
Top Buys
| 1 |
Pfizer
PFE
|
$1.24M |
| 2 |
ZimVie
ZIMV
|
$242K |
| 3 |
Cerence
CRNC
|
$231K |
| 4 |
Calix
CALX
|
$133K |
| 5 |
Advanced Energy
AEIS
|
$116K |
Top Sells
| 1 |
KLA
KLAC
|
$11.1M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$9.56M |
| 3 |
Charles Schwab
SCHW
|
$8.93M |
| 4 |
Synopsys
SNPS
|
$7M |
| 5 |
Microsoft
MSFT
|
$4.25M |
Sector Composition
| 1 | Technology | 41.59% |
| 2 | Communication Services | 15% |
| 3 | Healthcare | 14.31% |
| 4 | Consumer Discretionary | 14.29% |
| 5 | Financials | 11.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Cardinal Health
CAH
$35.6B
| $2.3M | 0.14% |
40,540
| – | – |
|
77
Verint Systems
VRNT
$1.23B
| $2.29M | 0.14% |
44,220
| – | – |
|
78
Exelixis
EXEL
$9.93B
| $2.25M | 0.14% |
99,343
| – | – |
|
79
F5
FFIV
$18.1B
| $2.2M | 0.13% |
10,525
| – | – |
|
80
Thermo Fisher Scientific
TMO
$183B
| $2.19M | 0.13% |
3,703
-397
| -10% | -$234K |
|
81
Tesla
TSLA
$1.08T
| $2.09M | 0.13% |
5,817
| – | – |
|
|
PRFT
82
DELISTED
Perficient Inc
PRFT
| $2.03M | 0.12% |
18,417
| – | – |
|
83
Concentrix
CNXC
$3.28B
| $2M | 0.12% |
12,000
| – | – |
|
84
Merck
MRK
$209B
| $1.95M | 0.12% |
23,765
| – | – |
|
85
Applied Industrial Technologies
AIT
$10.1B
| $1.94M | 0.12% |
18,875
| – | – |
|
86
Ambarella
AMBA
$3.42B
| $1.82M | 0.11% |
17,306
+240
| +1% | +$25.2K |
|
87
Ubiquiti
UI
$34.2B
| $1.81M | 0.11% |
6,212
| – | – |
|
88
Charles River Laboratories
CRL
$7.96B
| $1.78M | 0.11% |
6,284
-600
| -9% | -$170K |
|
89
Vertex Pharmaceuticals
VRTX
$101B
| $1.63M | 0.1% |
6,228
-178
| -3% | -$46.4K |
|
90
Johnson & Johnson
JNJ
$428B
| $1.62M | 0.1% |
9,148
| – | – |
|
91
Neurocrine Biosciences
NBIX
$13.7B
| $1.53M | 0.09% |
16,361
| – | – |
|
92
Lam Research
LRCX
$127B
| $1.5M | 0.09% |
27,850
| – | – |
|
93
Paylocity
PCTY
$9.73B
| $1.49M | 0.09% |
7,220
| – | – |
|
94
Mastercard
MA
$538B
| $1.48M | 0.09% |
4,149
| – | – |
|
95
Fortinet
FTNT
$58.7B
| $1.42M | 0.09% |
20,800
| – | – |
|
96
Humana
HUM
$37.6B
| $1.36M | 0.08% |
3,130
| – | – |
|
|
97
Calix
CALX
$3.97B
| $1.34M | 0.08% |
31,244
+3,095
| +11% | +$133K |
|
98
Medpace
MEDP
$13.4B
| $1.33M | 0.08% |
8,097
| – | – |
|
99
Biogen
BIIB
$20.3B
| $1.13M | 0.07% |
5,355
-650
| -11% | -$137K |
|
100
CSG Systems International
CSGS
$1.85B
| $1.1M | 0.07% |
17,373
+1,000
| +6% | +$63.5K |
|